chr4-6301306-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_006005.3(WFS1):c.1511C>T(p.Pro504Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000279 in 1,611,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P504R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.1511C>T | p.Pro504Leu | missense_variant | 8/8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.1511C>T | p.Pro504Leu | missense_variant | 8/8 | NP_001139325.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFS1 | ENST00000226760.5 | c.1511C>T | p.Pro504Leu | missense_variant | 8/8 | 1 | NM_006005.3 | ENSP00000226760.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249534Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135116
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1459028Hom.: 0 Cov.: 100 AF XY: 0.0000248 AC XY: 18AN XY: 725938
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74382
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 19, 2024 | Reported as heterozygous in two patients with type 1 diabetes (PMID: 31264968); Published functional studies demonstrate that P504L leads to increased degradation of the WFS1 protein (PMID: 16806192); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15277431, 24890733, 31589614, 15151504, 11161832, 12955714, 9771706, 36208030, 36147510, 34746052, 37444722, 34258273, 31264968, 15605410, 28432734, 16806192) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 504 of the WFS1 protein (p.Pro504Leu). This variant is present in population databases (rs28937892, gnomAD 0.009%). This missense change has been observed in individuals with autosomal recessive Wolfram syndrome (PMID: 9771706, 15277431, 24890733). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4512). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WFS1 protein function. Experimental studies have shown that this missense change affects WFS1 function (PMID: 16806192). For these reasons, this variant has been classified as Pathogenic. - |
Wolfram syndrome 1 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 09, 2023 | Variant summary: WFS1 c.1511C>T (p.Pro504Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 249854 control chromosomes (gnomAD and publication data). c.1511C>T has been reported in the literature in multiple individuals affected with Wolfram Syndrome 1 (Inoue_1998, Gmez-Zaera_2001, Astuti_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and this variant results in decreasing protein stability (Hofmann_2006) . The following publications have been ascertained in the context of this evaluation (PMID: 28432734, 11161832, 16806192, 9771706). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n=3) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Type 2 diabetes mellitus;C1833021:Autosomal dominant nonsyndromic hearing loss 6;C3280358:Wolfram-like syndrome;C3805412:Cataract 41;C4551693:Wolfram syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 17, 2022 | - - |
WFS1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 07, 2024 | The WFS1 c.1511C>T variant is predicted to result in the amino acid substitution p.Pro504Leu. This variant has been reported in the compound heterozygous state in multiple patients with Wolfram syndrome (Inoue et al. 1998. PubMed ID: 9771706; Chaussenot et al. 2014. PubMed ID: 24890733) and was also reported in two patients with type 1 diabetes (Table S6, Yu et al. 2019. PubMed ID: 31264968). This variant is reported in 0.0085% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as pathogenic. - |
Wolfram-like syndrome;C4551693:Wolfram syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Sep 28, 2021 | ACMG classification criteria: PS3 supporting, PS4 moderate, PM2 moderate, PM3 strong, PP1 supporting, PP3 supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at